Cardiff Oncology
CRDF
CRDF
110 hedge funds and large institutions have $52M invested in Cardiff Oncology in 2025 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 30 increasing their positions, 30 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
5.27% less ownership
Funds ownership: 43.08% → 37.81% (-5.3%)
42% less capital invested
Capital invested by funds: $90.3M → $52M (-$38.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
110
Holding in Top 10
–
Calls
$2.64M
Puts
$902K
Top Buyers
| 1 | +$1.38M | |
| 2 | +$1.14M | |
| 3 | +$1.12M | |
| 4 |
Goldman Sachs
New York
|
+$779K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$430K |
Top Sellers
| 1 | -$4.48M | |
| 2 | -$2.25M | |
| 3 | -$999K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$958K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$941K |
